← United States · Coverage record
US · SEC FORM 4
Tango Therapeutics, Inc.
TNGX · Nasdaq · CIK 0001819133 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
27 Form 4 transaction lines observed in the same window
14 sales · 13 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-11-18 · Rothenberg Mace.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 44,500,110
- Previous report
- 41,872,812
- Avg daily volume
- 3,547,777
- Days to cover
- 12.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2024-11-18 | Rothenberg Mace | Purchase (P) | Common Stock | 10,000 | USD 3.78 | USD 37,800 | SEC filing ↗ |
| 2024-11-14 | Rothenberg Mace | Purchase (P) | Common Stock | 10,000 | USD 3.62 | USD 36,200 | SEC filing ↗ |
| 2023-10-16 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 500,000 | USD 6.84 | USD 3,420,000 | SEC filing ↗ |
| 2023-10-16 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 500,000 | USD 6.84 | USD 3,420,000 | SEC filing ↗ |
| 2023-10-13 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 750,000 | USD 7.07 | USD 5,302,500 | SEC filing ↗ |
| 2023-10-13 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 750,000 | USD 7.07 | USD 5,302,500 | SEC filing ↗ |
| 2023-08-11 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 475,000 | USD 5.15 | USD 2,446,250 | SEC filing ↗ |
| 2022-10-13 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 70,000 | USD 4.65 | USD 325,500 | SEC filing ↗ |
| 2022-10-12 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 50,000 | USD 4.43 | USD 221,500 | SEC filing ↗ |
| 2022-10-11 | Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC | Purchase (P) | Common Stock | 117,000 | USD 4.25 | USD 497,250 | SEC filing ↗ |
| 2022-10-06 | Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH | Purchase (P) | Common Stock | 70,394 | USD 4.06 | USD 285,800 | SEC filing ↗ |
| 2022-10-05 | Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH | Purchase (P) | Common Stock | 86,000 | USD 3.89 | USD 334,335 | SEC filing ↗ |
| 2022-10-04 | Boxer Asset Management Inc.; Boxer Capital, LLC; LEWIS JOSEPH | Purchase (P) | Common Stock | 25,606 | USD 3.67 | USD 93,974 | SEC filing ↗ |
| 2020-09-08 | BCTG Holdings, LLC | Purchase (P) | Common Stock | 533,500 | USD 10.00 | USD 5,335,000 | SEC filing ↗ |
Form 4 evidence
47 transaction lines in the latest 365-day window; 152 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 24.47 | USD 660,796 | SEC filing ↗ |
| 2026-10-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-09-22 | Newcomb Jessica | Sale (S) | Common Stock | 8,200 | USD 24.22 | USD 198,615 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 24.47 | USD 660,796 | SEC filing ↗ |
| 2026-10-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-09-22 | Newcomb Jessica | Sale (S) | Common Stock | 8,200 | USD 24.22 | USD 198,615 | SEC filing ↗ |
| 2026-09-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 22.37 | USD 603,990 | SEC filing ↗ |
| 2026-09-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-08-03 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 27.24 | USD 735,500 | SEC filing ↗ |
| 2026-08-03 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-07-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 29.59 | USD 798,888 | SEC filing ↗ |
| 2026-07-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-06-19 | Azelby Robert | Award / grant (A) | Common Stock | 5,740 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | Rothenberg Mace | Award / grant (A) | Common Stock | 4,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | Lee Sung | Award / grant (A) | Common Stock | 570 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | Ketchum John B | Award / grant (A) | Common Stock | 4,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | Calhoun Lesley Ann | Award / grant (A) | Common Stock | 4,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 22.88 | USD 617,647 | SEC filing ↗ |
| 2026-06-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-05-01 | Gall Matthew | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 21.22 | USD 573,021 | SEC filing ↗ |
| 2026-05-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-04-29 | Lee Sung | Award / grant (A) | Common Stock | 12,300 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-15 | Crystal Adam | Sale (S) | Common Stock | 38,460 | USD 25.00 | USD 961,500 | SEC filing ↗ |
| 2026-04-15 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 38,460 | USD 5.20 | USD 199,992 | SEC filing ↗ |
| 2026-04-01 | Crystal Adam | Sale (S) | Common Stock | 27,000 | USD 21.20 | USD 572,400 | SEC filing ↗ |
| 2026-04-01 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 27,000 | USD 5.20 | USD 140,400 | SEC filing ↗ |
| 2026-03-25 | Crystal Adam | Sale (S) | Common Stock | 12,000 | USD 20.11 | USD 241,320 | SEC filing ↗ |
| 2026-03-25 | Crystal Adam | Option exercise / conversion (M) | Common Stock | 12,000 | USD 5.20 | USD 62,400 | SEC filing ↗ |
| 2026-03-05 | Crystal Adam | Sale (S) | Common Stock | 20,251 | USD 15.00 | USD 303,765 | SEC filing ↗ |
| 2026-02-25 | Crystal Adam | Sale (S) | Common Stock | 54,345 | USD 12.77 | USD 693,986 | SEC filing ↗ |
| 2026-02-03 | Weber Barbara | Sale (S) | Common Stock | 30,519 | USD 12.27 | USD 374,376 | SEC filing ↗ |
| 2026-02-03 | Crystal Adam | Sale (S) | Common Stock | 18,452 | USD 12.27 | USD 226,350 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TNGX |
| CIK | 0001819133 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 152 transaction lines from 2020-09-08 to 2026-10-01 15 P purchase lines · 85 S sale lines · 52 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.